MBX Biosciences (MBX) News Today $17.00 +0.87 (+5.39%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$16.89 -0.11 (-0.65%) As of 10/24/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock MBX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period MBX Biosciences (NASDAQ:MBX) Trading 9.9% Higher - Time to Buy?October 24 at 2:45 PM | marketbeat.comMBX Biosciences (NASDAQ:MBX) Shares Gap Up Following Insider Buying ActivityOctober 23 at 2:31 AM | americanbankingnews.comMBX Biosciences (NASDAQ:MBX) CEO Buys $272,800.00 in StockOctober 22 at 4:59 AM | insidertrades.comTD Asset Management Inc Has $1.96 Million Holdings in MBX Biosciences, Inc. $MBXOctober 22 at 3:51 AM | marketbeat.comMBX Biosciences (NASDAQ:MBX) CEO Acquires $272,800.00 in StockOctober 21, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Shares Gap Up After Insider Buying ActivityOctober 21, 2025 | marketbeat.comInsider Buying: MBX Biosciences (NASDAQ:MBX) Director Buys 20,000 Shares of StockOctober 21, 2025 | insidertrades.comMBX Biosciences (NASDAQ:MBX) Director Acquires $265,000.00 in StockOctober 20, 2025 | marketbeat.comMBX Biosciences to Participate in November Investor ConferencesOctober 20, 2025 | globenewswire.comMBX Biosciences (NASDAQ:MBX) Shares Down 4% - Time to Sell?October 18, 2025 | marketbeat.comStocks With Rising Relative Strength: MBX BiosciencesOctober 16, 2025 | msn.comTruist Securities Initiates Coverage of MBX Biosciences (MBX) with Buy RecommendationOctober 15, 2025 | msn.comMBX Biosciences (NASDAQ:MBX) Now Covered by Analysts at Truist FinancialOctober 15, 2025 | marketbeat.comMBX Biosciences initiated with a Buy at TruistOctober 15, 2025 | msn.com8Dell, 89bio, MBX Biosciences and More Stocks See Action From Activist InvestorsOctober 10, 2025 | msn.comMBX Biosciences (NASDAQ:MBX) Earns "Sell (D-)" Rating from Weiss RatingsOctober 10, 2025 | marketbeat.comInsiders Snap Up $54M in Biotech and Offshore Driller StocksOctober 7, 2025 | 247wallst.comHedge Fund and Insider Trading News: George Soros, David Tepper, Warren Buffett, Davidson Kempner, Bridgewater Associates, Jain Global, MBX Biosciences Inc (MBX), United ...October 2, 2025 | insidermonkey.comPlatinum Investment Management Ltd. Lowers Stock Holdings in MBX Biosciences, Inc. $MBXOctober 2, 2025 | marketbeat.comMBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of "Buy" by BrokeragesOctober 2, 2025 | marketbeat.comMBX Biosciences director buys $12.0M in common stockOctober 1, 2025 | msn.comPatrick Heron Buys 666,666 Shares of MBX Biosciences (NYSE:MBX) StockOctober 1, 2025 | insidertrades.comMassive Stock Purchase by MBX Biosciences Director!September 30, 2025 | tipranks.comMBX Biosciences (NYSE:MBX) Director Patrick Heron Purchases 666,666 SharesSeptember 30, 2025 | marketbeat.comMBX Biosciences (MBX) Price Target Increased by 48.48% to 57.12September 30, 2025 | msn.comGoldman Sachs Group Inc. Has $112,000 Stock Holdings in MBX Biosciences, Inc. $MBXSeptember 30, 2025 | marketbeat.comMBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic ForumSeptember 29, 2025 | globenewswire.comMBX Biosciences, Inc.: MBX Biosciences Announces Proposed Public OfferingSeptember 25, 2025 | finanznachrichten.deMBX Biosciences stock falls after pricing upsized public offeringSeptember 25, 2025 | za.investing.comMBX Biosciences Shares Drop Following Upsized Public Offering PricingSeptember 25, 2025 | msn.comMBX Biosciences (NYSE:MBX) Shares Gap Down - Should You Sell?September 25, 2025 | marketbeat.comMBX Biosciences (NASDAQ:MBX) Shares Gap Down - Time to Sell?September 25, 2025 | marketbeat.comMBX Biosciences price target raised to $56 from $38 at MizuhoSeptember 25, 2025 | msn.comMBX Biosciences 11.1M share Secondary priced at $18.00September 25, 2025 | msn.comMBX Biosciences stock down on pricing upsized public offering at $18.00 per shareSeptember 25, 2025 | msn.comMBX Biosciences, Inc. - Special CallSeptember 24, 2025 | seekingalpha.comMBX Biosciences, Inc. (MBX) Discusses On Topline Results From Avail Phase 2 Trial TranscriptSeptember 24, 2025 | seekingalpha.comMBX Biosciences Announces Pricing of Upsized Public OfferingSeptember 24, 2025 | globenewswire.comMBX Biosciences, Inc. (MBX) Biosciences, Inc. - Special Call - SlideshowSeptember 24, 2025 | seekingalpha.comMizuho Increases MBX Biosciences (NYSE:MBX) Price Target to $56.00September 24, 2025 | marketbeat.comMBX Biosciences (MBX) Is Up 84.0% After Positive Phase 2 Results for Canvuparatide - Has The Bull Case Changed?September 23, 2025 | finance.yahoo.comMBX Biosciences (NASDAQ:MBX) Sees Unusually-High Trading Volume - Still a Buy?September 23, 2025 | marketbeat.comMBX Biosciences (NYSE:MBX) Sees Unusually-High Trading Volume - Here's WhySeptember 23, 2025 | marketbeat.comMBX Biosciences Shares Climb on Planned Release of Trial DataSeptember 22, 2025 | marketwatch.comMBX Biosciences stock soars after hypoparathyroidism drug hits trial goalSeptember 22, 2025 | za.investing.comMBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label ...September 22, 2025 | markets.businessinsider.comMBX Biosciences Stock Doubles On Promising New Thyroid Disease TreatmentSeptember 22, 2025 | msn.comMBX Biosciences Shares Halt in Premarket Trading as Hypoparathyroidism Drug Shows Positive Phase 2 ResultsSeptember 22, 2025 | marketwatch.comMBX Biosciences' Experimental Drug Shows Promise In Hypoparathyroidism StudySeptember 22, 2025 | finance.yahoo.comMBX Biosciences Looks A Buy As Hypoparathyroidism Data Wows MarketSeptember 22, 2025 | seekingalpha.com Get MBX Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for MBX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MBX Media Mentions By Week MBX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MBX News Sentiment▼1.371.50▲Average Manufacturing News Sentiment MBX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MBX Articles This Week▼123▲MBX Articles Average Week Get the Latest News and Ratings for MBX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for MBX Biosciences and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies RCUS News Today TLRY News Today TWST News Today IMCR News Today BHVN News Today ABCL News Today PAHC News Today JANX News Today EWTX News Today GPCR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MBX) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | Sponsored$4,200 gold is nice ... but here’s what most gold bugs are missingGold just surged past $4,200, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MBX Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share MBX Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MBX Stock Alerts